APRIL, 19, 2023
Data Highlights the Value of HeartCare and AlloSure Lung in Clinical Practice
Leading Experts Present Latest Advancements in Heart and Lung Transplantation During CareDx Symposia
BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced a leading presence at the 43rd annual meeting & scientific sessions of the International Society for Heart and Lung Transplantation (ISHLT) with over 55 oral presentations and posters, and two symposia covering the latest advancements in surveillance and the clinical utility of these advancements in real-world applications for both heart and lung transplantation. The event will be held April 19-22 in Denver, Colorado. Read the complete press release on CareDx.com.